Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Axitinib> ?p ?o. }
Showing items 1 to 93 of
93
with 100 items per page.
- Axitinib abstract "Axitinib (AG013736; trade name Inlyta) is a small molecule tyrosine kinase inhibitor developed by Pfizer. It has been shown to significantly inhibit growth of breast cancer in xenograft models and has been successful in clinical trials with renal cell carcinoma (RCC) and several other tumour types.".
- Axitinib atcPrefix "L01".
- Axitinib atcSuffix "XE17".
- Axitinib bioavailability "58.0".
- Axitinib casNumber "319460-85-0".
- Axitinib chEBI "66910".
- Axitinib fdaUniiCode "C9LVQ0YUXG".
- Axitinib iupacName "N-Methyl-2-3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide".
- Axitinib pubchem "6450551".
- Axitinib thumbnail Axitinib2DACS.svg?width=300.
- Axitinib wikiPageID "14705695".
- Axitinib wikiPageRevisionID "606295807".
- Axitinib atcPrefix "L01".
- Axitinib atcSuffix "XE17".
- Axitinib bioavailability "58.0".
- Axitinib c "22".
- Axitinib casNumber "319460".
- Axitinib chebi "66910".
- Axitinib chembl "1289926".
- Axitinib chemspiderid "4953153".
- Axitinib eliminationHalfLife "-21960.0".
- Axitinib excretion "Faeces , urine".
- Axitinib h "18".
- Axitinib hasPhotoCollection Axitinib.
- Axitinib image "Axitinib3Dan.gif".
- Axitinib inchi "1".
- Axitinib inchikey "RITAVMQDGBJQJZ-FMIVXFBMBT".
- Axitinib iupacName "N-Methyl-2-3-[(E)-2-pyridin-2-ylethenyl]-1H-indazol-6-yl]sulfanyl]benzamide".
- Axitinib kegg "D03218".
- Axitinib legalAu "S4".
- Axitinib legalCa "Rx-only".
- Axitinib legalUk "POM".
- Axitinib legalUs "Rx-only".
- Axitinib licenceEu "Inlyta".
- Axitinib licenceUs "Axitinib".
- Axitinib medlineplus "a612017".
- Axitinib metabolism "Hepatic".
- Axitinib molecularWeight "386.469".
- Axitinib n "4".
- Axitinib o "1".
- Axitinib pdbLigand "AXI".
- Axitinib pregnancyAu "D".
- Axitinib pregnancyUs "D".
- Axitinib proteinBound ">99%".
- Axitinib pubchem "6450551".
- Axitinib routesOfAdministration "Oral".
- Axitinib s "1".
- Axitinib smiles "O=Cc4ccccc4Sc1ccc2cnnc2\C=C\c3ncccc3".
- Axitinib stdinchi "1".
- Axitinib stdinchikey "RITAVMQDGBJQJZ-FMIVXFBMSA-N".
- Axitinib tradename "Inlyta".
- Axitinib unii "C9LVQ0YUXG".
- Axitinib verifiedfields "changed".
- Axitinib verifiedrevid "458042196".
- Axitinib watchedfields "changed".
- Axitinib width "220".
- Axitinib width "250".
- Axitinib subject Category:Alkenes.
- Axitinib subject Category:Benzamides.
- Axitinib subject Category:Indazoles.
- Axitinib subject Category:Pyridines.
- Axitinib subject Category:Receptor_tyrosine_kinase_inhibitors.
- Axitinib subject Category:Thioethers.
- Axitinib type Abstraction100002137.
- Axitinib type AliphaticCompound114601294.
- Axitinib type Alkene114713120.
- Axitinib type Alkenes.
- Axitinib type Base114618253.
- Axitinib type Chemical114806838.
- Axitinib type Compound114818238.
- Axitinib type Material114580897.
- Axitinib type Matter100020827.
- Axitinib type OrganicCompound114727670.
- Axitinib type Part113809207.
- Axitinib type PhysicalEntity100001930.
- Axitinib type Pyridine114692510.
- Axitinib type Pyridines.
- Axitinib type Relation100031921.
- Axitinib type Substance100019613.
- Axitinib type Drug.
- Axitinib type DrugProduct.
- Axitinib type FunctionalSubstance.
- Axitinib comment "Axitinib (AG013736; trade name Inlyta) is a small molecule tyrosine kinase inhibitor developed by Pfizer. It has been shown to significantly inhibit growth of breast cancer in xenograft models and has been successful in clinical trials with renal cell carcinoma (RCC) and several other tumour types.".
- Axitinib label "Axitinib".
- Axitinib label "Axitinib".
- Axitinib sameAs Axitinib.
- Axitinib sameAs m.03gtr_v.
- Axitinib sameAs Q4830631.
- Axitinib sameAs Q4830631.
- Axitinib sameAs Axitinib.
- Axitinib wasDerivedFrom Axitinib?oldid=606295807.
- Axitinib depiction Axitinib2DACS.svg.
- Axitinib isPrimaryTopicOf Axitinib.